- Home
- STRO vs NAZ Comparison
STRO vs NAZ Comparison
Compare STRO & NAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- NAZ
- Stock Information
- Founded
- STRO 2003
- NAZ 1992
- Country
- STRO United States
- NAZ United States
- Employees
- STRO 306
- NAZ N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- NAZ Finance/Investors Services
- Sector
- STRO Health Care
- NAZ Finance
- Exchange
- STRO Nasdaq
- NAZ Nasdaq
- Market Cap
- STRO 165.7M
- NAZ 139.4M
- IPO Year
- STRO 2018
- NAZ N/A
- Fundamental
- Price
- STRO $2.01
- NAZ $11.96
- Analyst Decision
- STRO Strong Buy
- NAZ
- Analyst Count
- STRO 7
- NAZ 0
- Target Price
- STRO $12.14
- NAZ N/A
- AVG Volume (30 Days)
- STRO 984.3K
- NAZ 18.3K
- Earning Date
- STRO 11-13-2024
- NAZ 01-01-0001
- Dividend Yield
- STRO N/A
- NAZ 3.69%
- EPS Growth
- STRO N/A
- NAZ N/A
- EPS
- STRO N/A
- NAZ N/A
- Revenue
- STRO $160,955,000.00
- NAZ N/A
- Revenue This Year
- STRO N/A
- NAZ N/A
- Revenue Next Year
- STRO N/A
- NAZ N/A
- P/E Ratio
- STRO N/A
- NAZ N/A
- Revenue Growth
- STRO 230.90
- NAZ N/A
- 52 Week Low
- STRO $1.67
- NAZ $9.22
- 52 Week High
- STRO $6.13
- NAZ $11.37
- Technical
- Relative Strength Index (RSI)
- STRO 46.47
- NAZ 57.36
- Support Level
- STRO $1.72
- NAZ $11.90
- Resistance Level
- STRO $2.15
- NAZ $12.16
- Average True Range (ATR)
- STRO 0.14
- NAZ 0.16
- MACD
- STRO 0.05
- NAZ 0.08
- Stochastic Oscillator
- STRO 70.83
- NAZ 77.27
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About NAZ Nuveen Arizona Quality Municipal Income Fund
Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to provide current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.